Table 4 Cox multivariate analysis of prognostic factors on overall survival
From: p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma
Variable | Hazards ratio | 95% CI* | P value |
|---|---|---|---|
Age (>45.89 vs. ≤45.89) | 3.14 | 1.58–6.25 | 0.001 |
Clinical stage (III-IV vs. I-II) | 3.27 | 1.00–10.67 | 0.050 |
Relapse (Yes vs. No) | 5.97 | 3.10–11.49 | 0.000 |
p53R2 expression (High vs. Low) | 0.39 | 0.18–0.85 | 0.018 |